Safety and efficacy of 48 mm Xience Xpedition everolimus‐eluting stent for the treatment of long coronary lesions-Reference-Cited by-同舟云学术

Safety and efficacy of 48 mm Xience Xpedition everolimus‐eluting stent for the treatment of long coronary lesions

Published:2022-05-27 Issue:2 Volume:100 Page:179-187
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Cathet Cardio Intervent

Author:

Gautier Alexandre¹^ORCID,Hovasse Thomas¹,Arroyo Diego²,Unterseeh Thierry¹,Garot Philippe¹,Champagne Stéphane¹,Neylon Antoinette¹,Sanguineti Francesca¹,Benamer Hakim¹,Chevalier Bernard¹,Lefèvre Thierry¹

Affiliation:

1. Institut Cardiovasculaire Paris Sud, Hôpital Privé Jacques Cartier Massy France

2. Hôpital Fribourgeois, Service de Cardiologie Fribourg Suisse Switzerland

Funder

Abbott Laboratories

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccd.30249

Reference26 articles.

1. Drug-Eluting Coronary-Artery Stents

2. Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents

3. Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials

4. 5-Year Results of a Randomized Comparison of XIENCE V Everolimus-Eluting and TAXUS Paclitaxel-Eluting Stents

5. Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Safety and Performance of BioMime™ Morph Sirolimus-Eluting Coronary Stent System for Very Long Coronary Lesions;Cardiology Research;2024-06

2. Highlights From the Society for Cardiovascular Angiography & Interventions (SCAI) Scientific Sessions 2023;Journal of the American Heart Association;2024-04-02

3. Second-generation everolimus-eluting intracoronary stents: a comprehensive review of the clinical evidence;Future Cardiology;2024-01-31

4. One-year Outcomes of XIENCE Skypoint 48-mm Drug-Eluting Stents in Long Coronary Lesions: The SPIRIT 48 Trial;Journal of the Society for Cardiovascular Angiography & Interventions;2023-07

5. Impact of the ultra‐long 48 mm drug‐eluting stent on procedural and clinical outcomes in patients with diffuse long coronary artery disease;Clinical Cardiology;2023-02-20